June 19, 2013 article IgA Nephropathy New England Journal of Medicine DOI: 10.1056/nejmra1206793 OpenAlex Authors 0 Author list not loaded yet. Cited by 23 stored of 1,226 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Microscopic hematuria in IgA nephropathy: a biomarker of disease activity 2026 Clinical Kidney Journal article Medicine Renal Diseases and Glomerulopathies Open access 7 citations RNA-based therapeutic opportunities for the treatment of kidney diseases 2025 Nature Reviews Nephrology review Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery 8 citations Dilemma of missing specific disease codes: an approach to assess the incidence and prevalence of a rare nephrology disease 2025 BMC Nephrology article Health Professions Medical Coding and Health Information Open access 1 citations Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 30 citations Treatment of patients with IgA nephropathy: a call for a new paradigm 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 76 citations First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors 2024 Clinical Kidney Journal article Medicine Renal Diseases and Glomerulopathies Open access 14 citations The humanistic burden of immunoglobulin A nephropathy on patients and care-partners in the United States 2024 Quality of Life Research article Medicine Renal Diseases and Glomerulopathies Open access 4 citations Therapy of IgA nephropathy: time for a paradigm change 2024 Frontiers in Medicine article Medicine Renal Diseases and Glomerulopathies Open access 43 citations A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy 2024 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 137 citations Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 305 citations Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy 2022 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 226 citations Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study 2022 Journal of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 16 citations Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy 2022 JAMA article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 360 citations The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? 2021 Journal of Clinical Medicine article Immunology and Microbiology Complement system in diseases Open access 50 citations Current treatment of IgA nephropathy 2021 Seminars in Immunopathology article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 149 citations Precision medicine in immunoglobulin A nephropathy: still a journey ahead 2021 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access 6 citations Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy 2020 Journal of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 22 citations Why Target the Gut to Treat IgA Nephropathy? 2020 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access cited by 4 patents 95 citations Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy 2020 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access cited by 18 patents 161 citations 1–20 of 23 Page 1 / 2 Next → References 0